Gossamer Bio Inc. (GOSS) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts GOSS Hot Sheet
Join SI Premium – FREE
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $16.96 million versus the consensus estimate of $4.71 million.
For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Jiangsu Etern (600105:CH) at Buy
- JPMorgan Reinstates Adidas AG (ADS:GR) (ADDYY) at Overweight
- UBS Starts Nantong Jianghai Capacitor (002484:CH) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
